The Candida parapsilosis complex has been described as the second or third most common yeast species isolated from patients with bloodstream infections worldwide. This complex consists of three species: C. parapsilosis sensu stricto, C. orthopsilosis, and C. metapsilosis. The distribution of species in this complex has never been studied in Thailand. Here we investigated the molecular epidemiology, in vitro on virulence factors, and antifungal susceptibility profiles of isolates of these three species collected from patients in Siriraj Hospital, Thailand, from 2011 to 2015. Of the 96 C. parapsilosis complex isolates analyzed, 66 (68.75%) were identified as C. parapsilosis sensu stricto, 28 (29.17%) as C. orthopsilosis, and two (2.08%) as C. metapsilosis. Most strains were isolated from blood (81.25%). Proteinase activity was only detected in four (6.06%) and two (7.14%) isolates of C. parapsilosis sensu stricto and C. orthopsilosis, respectively. Sixty (90.91%) isolates of C. parapsilosis sensu stricto, 12 (42.86%) isolates of C. orthopsilosis, and all C. metapsilosis isolates showed phospholipase activity. Psuedohyphae formation was only detected in 33 (50%) and 15 (53.57%) isolates of C. parapsilosis sensu stricto and C. orthopsilosis, respectively. All isolates were susceptible to caspofungin. Most (85-100%) isolates were susceptible to antifungal drugs, but 3.13 -6.25% were resistant to voriconazole and fluconazole. In conclusion, our findings revealed that C. parapsilosis sensu stricto was the most common species among clinical isolates of the C. parapsilosis complex, and the most commonly used antifungal agents generally exhibited good in vitro activity against these strains.
Introduction
A prevalence of invasive fungal infections caused by Candida has been increased in Asia-Pacific region. 1 Candida species are opportunistic fungal pathogens that cause a variety of diseases ranging from superficial mucocutaneous diseases to systemic infections. In one study in the United States, Candida was isolated from the bloodstream of 8 to 10% of patients analyzed. 2 Candida albicans has been reported to be the most common species found in clinical samples. However, the number of infections caused by Candida non-albicans (CNA) species has significantly increased to approximately 50% of all candidemia in the general patient population. 3 A recent shift from C. albicans to CNA as the predominant causative pathogen in cases of infection has been reported. 4, 5 Among CNA, the C. parapsilosis complex has emerged as a major cause of human disease especially in immunocompromised patients and hospitalized patients with underlying diseases associated with parenteral nutrition and intravascular catheters. The C. parapsilosis complex affects mainly critically ill patients from surgical intensive care units, neonates, and cancer patients. 2, 6, 7 Three groups in the yeast complex are recognized by molecular techniques such as ribosomal DNA sequencing or MALDI-TOF identification and represent three separate species: C. parapsilosis sensu stricto, C. orthopsilosis, and C. metapsilosis. 8, 9 Although closely related, the members of the C. parapsilosis complex differ from each other regarding their clinical characteristics, antifungal susceptibility patterns, and virulence. [10] [11] [12] [13] The C. parapsilosis complex shows lower virulence than C. albicans and other CNA species, most likely owing to their inability to form true hyphae. 14, 15 Slime production, biofilm formation, extracellular enzyme production, and psuedohyphae formation are significant virulence factors of the C. parapsilosis complex enabling adhesion and disruption of host tissue. 22, 23 In this study, C. parapsilosis complex isolates obtained from routine hemoculture and other specimens isolated from sterile body sites within patients admitted to Siriraj hospital a 2,400-bed tertiary-care university hospital in Bangkok, Thailand between 2011 and 2015 were investigated. We analyzed species distribution, in vitro on virulence factors, and antifungal drug susceptibility profiles.
Methods

Yeast strains
A total of 139 C. parapsilosis complex isolates were collected from 96 patients. Only one isolate per patient was selected for analysis because, typically, serial isolates from the same patient belong to the same genotype. 24 All C. parapsilosis complex isolates obtained from sterile body sites were collected by the Department of Microbiology Laboratory at Siriraj hospital from January 2011 to December 2015. Ethics approval was granted by the Siriraj Institutional Review Board, No. SI 091/2016.
Molecular identification
Identification of isolates was carried out by ITS sequence analysis. Yeast genomic DNA isolation was performed by the boiling method as described previously. 25 ITS regions were amplified using primers ITS1 (5 TCC-GTA-GGT-GAA-CCT-GCG-G 3 ) and ITS4 (5 TCC-TCC-GCT-TAT-TGA-TAT-GC 3 ) (BioDesign Co., Ltd., Thailand). Polymerase chsin reaction (PCR) amplification was performed as follows: 30 cycles of denaturation at 94
• C for 30 s, annealing at 48
• C for 1 min, and extension at 72
• C for 75 s;
followed by a final extension at 72
• C for 10 min. The amplicons were checked by 1.5% agarose gel electrophoresis. 26 The amplified DNA product, of approximately 520-bp in size, was then purified using a GenepHlow TM Gel/PCR kit as described by the manufacturer (Geneaid Biotech Ltd., Taiwan) . 27 Approximately, 50 ng of DNA sample were sequenced using the ITS1 and ITS4 primers on a 3730xl DNA analyzer (Macrogen Inc., Korea). The ITS nucleotide sequences of the C. parapsilosis complex were analyzed using the BLASTN program provided at the NCBI website (http://blast.ncbi.nlm.nih.gov/Blast.cgi). C. parapsilosis sensu stricto, C. orthopsilosis, and C. metapsilosis accession number KC253994, GQ152294 and GQ152229, respectively, were used for reference sequences.
Proteinase assay
Proteinase activities were determined on YCB-bovine serum albumin (YCB-BSA Phospholipase assay C. parapsilosis complex isolates were analyzed for phospholipase activity on Sabouraud dextrose agar (40 g/l Dextrose, 10 g/l Peptone, 15 g/l agar, and pH adjusted to 5.6; HiMedia, Mumbai, India) supplemented with 1 mol/l NaCl and 0.005 mol/l CaCl 2 . This solution was autoclaved and 10% v/v egg yolk emulsion (Merck Millipore, Germany) was added. A portion of 5 µl of yeast suspension containing 10 6 cells/ml were dropped onto the media surface and then incubated at 37
• C for 7 days. The presence of phospholipase was indicated by hydrolysis of the egg yolk in the egg yolk agar, resulting in a precipitin zone around the colony.
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Psuedohyphae formation
To investigate psuedohyphae formation, each well of a 24-well plastic cell culture plate containing 1 ml of Dulbecco's modified eagle medium (DMEM; Difco, Livonia, Michigan, USA) supplemented with 10% BSA (Merck Millipore, Germany) and 1% of 100 × penicillin-streptomycin solution (Difco, USA) was inoculated with 20 µl of a suspension containing 10 6 cells/ml of C. parapsilosis. The plate was incubated at 37
• C for 24 h. Psuedohyphae formation in each well was detected after 24 h under a light microscope (400×) for 20 areas/well. Strains were defined as positive for psuedohyphae formation when chains of elongated budding cells could be seen in more than 50% of the total areas analyzed.
11
Antifungal susceptibility testing
The drug susceptibilities of the C. parapsilosis isolates were determined by a commercial microdilution method, Sensititre R YeastOne R part YO10 (SYO) (Thermo Scientific, Schaumburg, Illinois, USA), according to the manufacturer's protocol. C. krusei ATCC 6258 and C. parapsilosis ATCC 22019 were used as the reference strains for quality control. Briefly, 100 µl of working yeast suspension (approximately 1.5 × 10 3 cells/ml) was added to each well using a multichannel pipetting device. The SYO panels were covered with adhesive seals and incubated at 35 
Results
Species distribution among C. parapsilosis complex isolates
During the 5-year study period, the percentages of invasive candidiasis caused by C. parapsilosis complex were isolated 22.43, 11.65, 11.22, 11.52, and 13.12% (13.99% on average) in 2011, 2012, 2013, 2014, and 2015, respectively ( Fig. 1) . A total of 96 strains were collected from cases of invasive candidiasis caused by the C. parapsilosis complex. Based on ITS sequence analysis, C. parapsilosis complex isolates were separated into 66 strains (68.75%) of C. parapsilosis sensu stricto, 28 strains (29.17%) of C. orthopsilosis, and two strains (2.08%) of C. metapsilosis. Blood (81.25%) was the most common site of isolation (Table 1) .
In vitro studies on virulence factors
Of the 96 isolates, 74 strains (77.08%) showed phospholipase activity, six strains (6.25%) showed proteinase activity, and 48 strains (50.00%) were positive for psuedohyphae formation. Phospholipase activity was detected in 60 (90.91%), 12 (42.86%), and two (100.00%) strains of C. parapsilosis sensu stricto, C. orthopsilosis, and C. metapsilosis, respectively. Proteinase activity was only detected in four (6.06%) and two (7.14%) strains of C. parapsilosis sensu stricto and C. orthopsilosis, respectively. Psuedohyphae formation was only detected in 33 (50.00%) and 15 (53.57%) strains of C. parapsilosis sensu stricto and C. orthopsilosis, respectively (Table 2) . In this study, a significant difference was detected in phospholipase activity only between C. parapsilosis sensu stricto and C. orthopsilosis strains (P-value < .0001) ( Table 2) .
Antifungal susceptibility testing
The susceptibilities of the strains to nine antifungal agents are shown in Table 3a -c. The mode MICs of echinocandins and 5-flucytosine in C. parapsilosis sensu stricto were minimally higher than C. orthopsilosis. On the other hand, the mode MICs of azole drugs (except voriconazole) in C. orthopsilosis were minimally higher than C. parapsilosis sensu stricto. C. parapsilosis sensu stricto had marginally higher geometric mean MICs than C. orthopsilosis in all antifungal agents. All C. parapsilosis complex strains were not resistant to all echinocandin. All C. parapsilosis complex strains represented wild-type strains according to the ECVs to anidulafungin and micafungin. All C. orthopsilosis and C. metapsilosis isolates were susceptible to echinocandin. 3.13% and 6.25% of all strains were resistant to voriconazole and fluconazole, respectively. Generally, C. parapsilosis sensu stricto was more resistant to antifungal agents than the other species in this complex (Table 3a -c).
Discussion
The C. parapsilosis complex has emerged as an important pathogen in hospitalized patients and, in particular, immunocompromised patients. 14, 33 Recently, multilocus sequence typing data provided evidence of genotypic differences in C. parapsilosis group I, II, and III leading to the separate two additional species in the C. parapsilosis complex, C. orthopsilosis, and C. metapsilosis. 8 Surveillance data about species distribution, antifungal susceptibility patterns, and in vitro studies on virulence factors of these three species are continually collected and accurate epidemiological information regarding invasive Candida infections is important to support guidelines for the empiric treatment of suspected infections. 34 A distribution of Candida species isolated from invasive candidiasis patients in our study showed an average C. parapsilosis complex prevalence of 13.99%. The prevalence was minimally higher than a previous study that found approximately 6-10% of total isolates in Thailand. [35] [36] [37] In Asia-Pacific region, C. parapsilosis complex was found approximately 7.8-36.0% of total isolates. 38 The data from AFTEMIS Global Surveillance Program 2001 to 2007 showed C. parapsilosis complex were isolated from 5.4 to 7.3% of patients having invasive candidiasis worldwide. 39 Therefore, there was no marked difference in our C. parapsilosis complex prevalence when comparing to other regions. Molecular epidemiology analysis in this study identified 68.75% of isolates analyzed as C. parapsilosis sensu stricto, which is similar to the prevalence rates reported in Italy, Spain, Malaysia, and Taiwan. 12, 13, 40, 41 In addition, this study showed a high percentage (29.17%) of C. orthopsilosis isolates. Previous studies have shown prevalence rates of candidemia due to C. metapsilosis ranging from 1.1% to 6.9% and for C. orthopsilosis ranging from 3.6% to 9% in North America and Europe. [42] [43] [44] This suggests that the epidemiology of the C. parapsilosis complex may be distinct in the Southeast Asia region from other regions of the world. Effective strategies to invade and grow within host tissue are essential for pathogenic fungi. It is thought that the C. parapsilosis complex produces virulence factors similarly to C. albicans, as shown by some previous in vitro studies on virulence factors. 2, 45 Proteinase enzyme has been directly linked to the invasive destruction of host tissue and increased proteinase activity among disease-related strains may indicate the importance of this enzyme in Candida pathogenicity. In our study, proteinase ability was detectable in only 6.25% (6/96) of C. parapsilosis complex isolates. One reason for this could be that only samples from sterile body sites were collected in this study. A previous study showed that extracellular proteinase production was more common for isolates from non-sterile sites such as the skin 46 and urogenital tract. 47 Thus, further sampling from other body sites is warranted. Phospholipase enzyme plays an active role in the invasion of host tissue by disrupting the epithelial cell membrane. In our study, phospholipase production was detectable in 90.91% (60/96) of C. parapsilosis sensu stricto, 42.86% (12/28) of C. orthopsilosis, and 100% (2/2) of C. metapsilosis isolates. This result was dissimilar to previous study that showed 30% of C. parapsilosis sensu stricto, 67% of C. orthopsilosis, and 20% of C. metapsilosis were phospholipase positive in clinical isolates from blood. 48 This difference might be due to variation of either strains' characteristics or environmental factors effecting phospholipase activity of C. parapsilosis complex such as different media for enzymatic test or biological variation among isolates. 49 Members of the C. parapsilosis complex do not produce true hyphae but are able to produce psuedohyphae, and this morphotype is a potential virulence factor that enables evasion of phagocytosis and penetration of the mucosal barrier. In our study, psuedohyphae formation was detectable in 50% (33/66) of C. parapsilosis sensu stricto and 53.57% (15/28) of C. orthopsilosis isolates. None of C. metapsilosis isolates exhibited psuedohyphae formation. This result is comparable to data from previous studies that showed all C. metapsilosis isolates did not develop psuedohyphae but 82-100% of C. parapsilosis sensu stricto isolates and 40-72% of C. orthopsilosis isolates could form psuedohyphae. 11, 50 The association between molecular epidemiology and in vitro studies on virulence factors showed that a greater number of C. parapsilosis sensu stricto isolates produced virulence factors than other species among this complex, especially for phospholipase production. Surprisingly, approximately 50% of C. orthopsilosis isolates produced phospholipase and psuedohyphae, which is in contrast to previous studies whereby C. orthopsilosis was reported to rarely produce these factors. 51, 52 In general, the antifungal susceptibility pattern of the C. parapsilosis complex reported in this study was similar to previous reports globally. Regarding the susceptibility results based on the CBPs, first, 6.25% (6/96) of all C. parapsilosis complex isolates in this study were resistant to fluconazole, which was similar to the results of European (6.3%) and North American (6.6%) studies. 53, 54 Second, three (3.13%) isolates of the C. parapsilosis complex were resistant to voriconazole, which is in line with previous reports of 0-20% resistance to the drug. 13 , 55 Third, we found that all C. parapsilosis complex isolates were susceptible to caspofungin and showed no resistance to echinocandins. 38, 56, 57 These data confirm echinocandins as the drugs of choice in clinically unstable or severely ill patients with invasive candidemia according to the IDSA guidelines. 58 When categorizing strains based on ECVs, all C. parapsilosis complex isolates showed wild-type profiles to anidulafungin and micafungin, which was in agreement with other previous studies. 37 Previous studies 13, 37, 59 showed all C. parapsilosis complex were wild-type to amphotericin B. Interestingly, our study found one C. parapsilosis sensu stricto isolate (1.52%) that represented nonwild type (MIC = 4 µg/ml). This is similar to a report from Wang et al. that reported one isolate of C. parapsilosis as non-wild-type. 60 However, this is not common in Thailand.
In conclusion, this study showed that C. parapsilosis sensu stricto was the most common species in the C. parapsilosis complex isolated from clinical specimens. This might be due to the fact that generally this species produce more virulence factors than other species. Though marginal, the higher resistant rate of C. parapsilosis sensu stricto might also play an important role for high prevalence of the sources in clinical specimens. However, further investigations on a greater number of C. parapsilosis complex isolates are needed as the number of isolates of the least common species, C. metapsilosis, was limited.
